Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Hyperbetaalaninemia is a very rare metabolic condition.Hyperbetaalaninemia refers to thebuild-upof protein building blocks, called beta amino acids, in the body. The excess beta amino acidsare neurotoxic to the body. Signs and symptoms of hyperbetaalaninemia includeconvulsions (rapid and uncontrollable shaking), lethargy, and encephalopathy.Hyperbetaalaninemia is thought to be due to a loss ofa functional form of the enzyme,beta-alanine-alpha-ketoglutarate transaminase.Treatment with oral pyridoxine wasdemonstrated to be helpful in one case.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for hyper-beta-alaninemia.
2 publications have been identified in PubMed for hyper-beta-alaninemia. Research spans Case Report / Case Series (100%).
Nguyen TTN (2024). [PMID: 39720099](https://pubmed.ncbi.nlm.nih.gov/39720099/). *Front Pediatr*. [Case Report / Case Series]
Rizkallah D (2024). [PMID: 38833093](https://pubmed.ncbi.nlm.nih.gov/38833093/). *Metab Brain Dis*. [Case Report / Case Series]
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 11:47 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center